UAB-MISS MACS/WIHS Combined Cohort Study

UAB-MISS MACS/WIHS 联合队列研究

基本信息

项目摘要

As the HIV epidemic has matured, understanding the impact of HIV on overall health becomes more important as HIV is managed as a chronic illness. This is particularly true in the Southeastern part of the United States, where the epidemic is worsening relative to other parts of the country. Alabama and Mississippi are located in the heart of the Deep South and have some of the highest rates of new HIV cases annually, especially among minorities. Barriers to access to care are among the worst in the US, and the prevalence of obesity, cardiovascular disease, cancer, and health care disparities are most pronounced. Therefore, studying people living with HIV in the Deep South will provide the opportunity to understand the current epidemic as it is emerging today. The University of Alabama at Birmingham (UAB) has a rich tradition of AIDS research, dating back to the mid-1980s. As the epidemic has matured, UAB scientists have established expertise in many areas, including psychosocial/behavioral, neurocognition, aging, cancer, pathogenesis, and health disparities. UAB scientists have emerged as leaders in innovative cohort research that evaluates the long-term outcomes via multisite cohort studies (e.g., CNICS, NA-ACCORD, ART-CC, and FRAM). By creating a linkage to the University of Mississippi Medical Center (UMMC) as a subaward partner, we take full advantage of their years of expertise in HIV clinical care, outreach, and cohort research. Collectively, we represent an ideal cohort for the MACS/WIHS Combined Cohort Study (CCS), both in terms of scientific expertise and representation of the current HIV epidemic in the US. The Specific Aims for our CCS site are: 1. To continue to provide scientific leadership and expertise within the CCS, focusing on psychosocial/behavioral, structural and genetic determinants of HIV and co-morbidity-related outcomes; neurocognition among aging PLWH; and immunopathogenesis of HIV disease. 2. To collect high-quality data and specimens from MACS/WIHS-CCS core and sub-study visits to contribute to the Unified Scientific Agenda (USA) and protocols; and collaborate with the overall team of MACS/WIHS-CCS investigators across sites. 3. To continue to achieve operational excellence by maintaining outstanding records for recruitment, retention, data quality and completeness and cost-effectiveness. 4. To ensure sharing of data/specimens with the data center, the NIH community and external investigators, and communication/engagement with local communities. 5. To develop, mentor and support junior and minority investigators in coordination with Developmental Award Advisory Committee (DARC). 6. To recruit and retain a cohort of 230 women and 270 men, HIV-positive and age-matched HIV- negative controls, who are strategically selected to enable the conduct of the USA.
随着艾滋病毒流行的成熟,了解艾滋病毒对整体健康的影响变得更加重要 因为艾滋病毒是作为一种慢性疾病来管理的。在美国东南部尤其如此, 与该国其他地区相比,该地区的疫情正在恶化。阿拉巴马州和密西西比州位于 位于南方腹地的中心地带,每年新发艾滋病毒病例率最高,尤其是 少数民族之间。获得医疗服务的障碍是美国最严重的障碍之一,而且肥胖症的流行, 心血管疾病、癌症和医疗保健方面的差距最为明显。因此,研究人 生活在南方腹地的艾滋病毒感染者将提供了解当前流行病现状的机会 今天出现。阿拉巴马大学伯明翰分校 (UAB) 拥有丰富的艾滋病研究传统,约会 回到20世纪80年代中期。随着疫情的成熟,阿拉巴马大学的科学家们在许多领域建立了专业知识 领域,包括心理社会/行为、神经认知、衰老、癌症、发病机制和健康差异。 阿拉巴马大学科学家已成为评估长期结果的创新队列研究的领导者 通过多中心队列研究(例如 CNICS、NA-ACCORD、ART-CC 和 FRAM)。通过创建到 密西西比大学医学中心 (UMMC) 作为子奖励合作伙伴,我们充分利用他们的多年经验 艾滋病毒临床护理、外展和队列研究方面的专业知识。总的来说,我们代表了一个理想的群体 MACS/WIHS 联合队列研究 (CCS),无论是在科学专业知识还是代表性方面 美国目前的艾滋病毒流行情况。我们 CCS 站点的具体目标是: 1. 继续在 CCS 内提供科学领导和专业知识,重点关注 HIV 和共病相关的心理社会/行为、结构和遗传决定因素 结果;老年感染者的神经认知;和艾滋病毒疾病的免疫发病机制。 2. 从 MACS/WIHS-CCS 核心和子研究访问中收集高质量数据和样本 为统一科学议程(美国)和协议做出贡献;并与整体协作 各站点的 MACS/WIHS-CCS 调查员团队。 3. 通过保持出色的招聘记录,继续实现卓越运营, 保留、数据质量和完整性以及成本效益。 4. 确保与数据中心、NIH 社区和外部共享数据/样本 调查人员以及与当地社区的沟通/接触。 5. 与以下机构协调,培养、指导和支持初级和少数族裔研究人员 发展奖咨询委员会(DARC)。 6. 招募并留住 230 名女性和 270 名男性,艾滋病毒呈阳性且年龄匹配的艾滋病毒感染者 负面控制,他们是经过战略选择以支持美国的行为。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Is there a link between premature ovarian failure and serum concentrations of vitamin D, zinc, and copper?
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James Benjamin Brock其他文献

James Benjamin Brock的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James Benjamin Brock', 18)}}的其他基金

A Multisite Randomized Trial of Viral Combat: A Mobile Gaming App to Improve Adherence to PrEP
病毒战斗的多站点随机试验:一款提高 PrEP 依从性的移动游戏应用程序
  • 批准号:
    10684653
  • 财政年份:
    2022
  • 资助金额:
    $ 291.84万
  • 项目类别:
A Multisite Randomized Trial of Viral Combat: A Mobile Gaming App to Improve Adherence to PrEP
病毒战斗的多站点随机试验:一款提高 PrEP 依从性的移动游戏应用程序
  • 批准号:
    10402149
  • 财政年份:
    2022
  • 资助金额:
    $ 291.84万
  • 项目类别:
A Multisite Randomized Trial of BattleViro: A Mobile Gaming App to Improve ART Adherence for Youth
BattleViro 的多站点随机试验:一款提高青少年 ART 依从性的移动游戏应用程序
  • 批准号:
    10175048
  • 财政年份:
    2018
  • 资助金额:
    $ 291.84万
  • 项目类别:
A Multisite Randomized Trial of BattleViro: A Mobile Gaming App to Improve ART Adherence for Youth
BattleViro 的多站点随机试验:一款提高青少年对 ART 依从性的移动游戏应用程序
  • 批准号:
    10421056
  • 财政年份:
    2018
  • 资助金额:
    $ 291.84万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 291.84万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 291.84万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 291.84万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 291.84万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 291.84万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 291.84万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 291.84万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 291.84万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 291.84万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 291.84万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了